Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine

Overview of attention for article published in The Journal of Headache and Pain, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet

policy: 1 policy source

Citations

dimensions_citation: 235 Dimensions

Readers on

mendeley: 173 Mendeley

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

galcanezumab

Cited by Canadian Agency for Drugs and Technologies in Health on 28 Feb 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.